Pharmacy News

Model cuts 5-year CVD event risk for Medicare patients

Results from a new study in JAMA found that the Million Hearts Model, which paid participating health care organizations to assess and reduce patients’ CVD risk, decreased myocardial infarction and stroke rates for Medicare fee-for-service beneficiaries aged 40 to 79 years at high or medium risk for these events.

Metformin could be beneficial for gestational diabetes

The use of metformin among pregnant women with gestational diabetes was associated with enhanced glycemic control and reduced gestational weight gain, according to a randomized, placebo-controlled study published in JAMA.

DEA extends telehealth authorities for controlled substances through 2024

DEA will continue to allow providers to use telemedicine to prescribe certain controlled substances through the end of 2024.

CDC develops antibiotic policy for reducing STIs

In proposed guidance published in the Federal Register, CDC is advising clinicians to offer gay and bisexual men and transgender women more access to doxycycline, a widely used tetracycline antibiotic, as post-exposure prophylaxis (PEP).

Study finds pharmacist intervention improved diabetes control for Hispanic patients

A new study published in JAMA Network Open found that an intervention involving patient assessments by trained pharmacists in conjunction with primary care physicians led to better glycemic control among Hispanic patients with T2D.